Enzon Pharmaceuticals, Inc. (BST:EZ1)
0.0555
-0.0045 (-7.50%)
At close: Aug 12, 2025
Enzon Pharmaceuticals Statistics
Total Valuation
BST:EZ1 has a market cap or net worth of EUR 5.01 million. The enterprise value is 4.37 million.
Market Cap | 5.01M |
Enterprise Value | 4.37M |
Important Dates
The last earnings date was Friday, August 8, 2025.
Earnings Date | Aug 8, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 74.21M |
Shares Outstanding | n/a |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 30.11M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 0.13 |
P/TBV Ratio | 13.61 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -1.97 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 55.71
Current Ratio | 55.71 |
Quick Ratio | 55.16 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -2.94% and return on invested capital (ROIC) is -4.43%.
Return on Equity (ROE) | -2.94% |
Return on Assets (ROA) | -4.37% |
Return on Invested Capital (ROIC) | -4.43% |
Return on Capital Employed (ROCE) | -7.30% |
Revenue Per Employee | n/a |
Profits Per Employee | -2.22M |
Employee Count | 1 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, BST:EZ1 has paid 271,629 in taxes.
Income Tax | 271,629 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -48.61% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -48.61% |
50-Day Moving Average | 0.06 |
200-Day Moving Average | 0.08 |
Relative Strength Index (RSI) | 42.27 |
Average Volume (20 Days) | 117 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -2.73M |
Pretax Income | -862,570 |
Net Income | -2.22M |
EBITDA | n/a |
EBIT | -2.73M |
Earnings Per Share (EPS) | -0.03 |
Balance Sheet
The company has 37.72 million in cash and n/a in debt, giving a net cash position of 37.72 million.
Cash & Cash Equivalents | 37.72M |
Total Debt | n/a |
Net Cash | 37.72M |
Net Cash Per Share | n/a |
Equity (Book Value) | 37.45M |
Book Value Per Share | 0.00 |
Working Capital | 37.41M |
Cash Flow
Operating Cash Flow | -561,990 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
BST:EZ1 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -44.34% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |